GW815SF HFA MDI

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW815SF HFA MDI, covering 2009-08-11 to 2009-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma [Phase 3]